NEW YORK (Reuters Health) - A new study suggests that injections of steroids or arthritis drugs in the spine may not provide much extra relief for people with chronic back and leg pain due to nerve ...
NEW YORK (Reuters Health) - In a new report, U.S. researchers describe the improvement in brain function that occurred in a patient with Alzheimer's disease just minutes after receiving an injection ...
US Food and Drug Administration staffers have concluded that Sandoz' biosimilar of Amgen's blockbuster Enbrel, dubbed GP2015, is "highly similar" to its reference product, pushing the drug closer to ...
SAN FRANCISCO (MedscapeWire) Nov 15 — The drug etanercept was effective in reducing the joint pain, stiffness, and swelling of patients with ankylosing spondylitis, researchers reported Thursday at ...
The competing rheumatoid arthritis drugs of Immunex Corp. and Johnson & Johnson may offer effective new approaches to easing the chronic skin flares of psoriasis, new research shows. A study presented ...
Noting that there was one death during the trial, the Subject Expert Committee (SEC), functional under the Central Drugs ...
Susan Estrich is the Robert Kingsley Professor of Law and Political Science at the University of Southern California Law Center as well as being a syndicated columnist. The U.S. government this week ...
WASHINGTON — Colorado is pioneering a new way for states to crack down on prescription drug costs. In a first-in-the-nation move, a state board voted to create a payment limit for a widely prescribed ...
Lupin is introducing Rymti, its first biosimilar in Canada, through its partner Sandoz Canada (Sandoz). Rymti is indicated for the treatment of moderate to severe active rheumatoid arthritis, juvenile ...
A Colorado board voted to move forward with setting a price ceiling on the arthritis drug Enbrel on Friday, a first-in-the-nation step that raises questions about whether a single state can reduce ...
The U.S. government this week released the list of the 10 medications that will be the first to be the subject of the new price negotiations under the Medicare reform bill, and my arthritis drug, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback